Phase 1 Psoriasis Trial, Recruiting NCT06846710 Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. Condition: Psoriasis
Back to Psoriasis

Phase 1 Psoriasis Trial, Recruiting

NCT06846710
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the single-dose part of the study (SAD):

  • You are a healthy adult between 18 and 45 years old
  • Men must weigh at least 50 kg and women at least 45 kg, and everyone must weigh no more than 110 kg, with a body mass index (BMI) between 18 and 28
  • Your general health checks, blood tests, heart tracing (ECG), ultrasound, and chest X-ray results are normal or show nothing of concern

For the multiple-dose part of the study (MAD):

  • You are a male or female between 18 and 65 years old
  • Men must weigh at least 50 kg and women at least 45 kg, and everyone must weigh no more than 110 kg
  • You have been diagnosed with chronic plaque psoriasis for at least 6 months, with or without psoriatic arthritis

Who may not be able to join:

For the single-dose part (SAD):

  • You have a history of immune system-related conditions or diseases
  • You have a history of drug allergies or the investigator believes you may be allergic to the study drug or its ingredients
  • You have used illegal drugs in the past 3 months, have a history of drug abuse in the past 5 years, or test positive on a urine drug screen

For the multiple-dose part (MAD):

  • You have a type of psoriasis other than chronic plaque psoriasis, such as guttate, pustular, erythrodermic, or drug-induced psoriasis, or another condition that could affect treatment results
  • You currently use or have recently used illegal drugs within specific timeframes (confirm with trial site)
  • You have a known history of repeated or long-term infections, serious infections such as blood poisoning or pneumonia, or have been hospitalised or received intravenous antibiotics for an infection within the past 2 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Registry
ClinicalTrials.gov
Start date
2 May 2025
Est. completion
30 October 2026

Where this trial is recruiting

🇳🇿 New Zealand 🇺🇸 United States

Primary endpoints

Incidence, severity and association with the study drug of adverse events (AEs), serious AEs (SAEs), and AEs leading to discontinuation; Number of participants with abnormalities of physical examination; Number of participants with abnormalities of vital signs; Number of participants with clinical laboratory abnormalities; Number of participants with abnormalities of electrocardiogram (ECG) parameters

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov